Bidvest Noonan has retained its multi-service contract with Alexion, AstraZeneca, a leading biopharmaceutical company that develops breakthrough therapies for rare diseases.
The contract renewal will see Bidvest Noonan continuing to provide services, including cleaning, M&E maintenance, and grounds maintenance, supporting Alexion’s state-of-the-art global manufacturing operations facilities in Ireland.
The renewal reinforces Bidvest Noonan’s reputation as a leading FM service partner in the Life Sciences sector. The company has invested significantly in this field, employing GMP and GLP experts, microbiologists, and specialists in contamination control programs that support world-leading life science companies.
Cormac Sheils, Chief Operations Officer at Bidvest Noonan, said: “We are delighted to continue our partnership with Alexion. Alexion is an outstanding company pursuing a very important mission. This renewal is a testament to the dedication and expertise of our service delivery and support teams, who work tirelessly for our clients.”
Mary Kealy, Managing Director at Bidvest Noonan, added: “We take great pride in the important work we do for Alexion and the successes we have achieved together. We are committed to helping them succeed and look forward to continuing our partnership.”